Sáinz MP, Pelayo R, Laxe S, Castaño B, Capdevilla E, Portell E. Describing post-polio syndrome.
Neurologia 2022;
37:346-354. [PMID:
31103313 DOI:
10.1016/j.nrl.2019.03.011]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 02/26/2019] [Accepted: 03/05/2019] [Indexed: 11/21/2022] Open
Abstract
INTRODUCTION
Patients presenting sequelae of poliomyelitis may present new symptoms, known as post-polio syndrome (PPS).
OBJECTIVE
To identify the clinical and functional profile and epidemiological characteristics of patients presenting PPS.
PATIENTS AND METHODS
We performed a retrospective study of 400 patients with poliomyelitis attended at the Institut Guttmann outpatient clinic, of whom 310 were diagnosed with PPS. We describe patients' epidemiological, clinical, and electromyographic variables and analyse the relationships between age of poliomyelitis onset and severity of the disease, and between sex, age of PPS onset, and the frequency of symptoms.
RESULTS
PPS was more frequent in women (57.7%). The mean age at symptom onset was 52.4 years, and was earlier in women. Age at primary infection >2 years was not related to greater poliomyelitis severity. The frequency of symptoms was: pain in 85% of patients, loss of strength in 40%, fatigue in 65.5%, tiredness in 57.8%, cold intolerance in 20.2%, dysphagia in 11.7%, cognitive complaints in 9%, and depressive symptoms in 31.5%. Fatigue, tiredness, depression, and cognitive complaints were significantly more frequent in women. Fifty-nine percent of patients presented electromyographic findings suggestive of PPS.
CONCLUSIONS
While the symptoms observed in our sample are similar to those reported in the literature, the frequencies observed are not. We believe that patients' clinical profile may be very diverse, giving more weight to such objective parameters as worsening of symptoms or appearance of weakness; analysis of biomarkers may bring us closer to an accurate diagnosis.
Collapse